ArticleJournal of applied clinical medical physics2026
Optimizing photon counting detector CT reconstructions for automatic vessel tracing in prostate artery embolization.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundProstate artery embolization (PAE) requires precise visualization of complex pelvic arterial anatomy and can be aided by advanced vessel navigation tools. Photon counting detector (PCD) CT provides simultaneous ultra-high resolution and material-specific imaging, potentially improving automatic vessel tracing workflow for procedural planning and guidance. PURPOSE: To identify, within a PCD-CT workflow, the reconstruction that provides the most robust and consistent automatic vessel tracing for pre-procedural PAE planning.
methodsTen patients underwent PCD-CT angiography of the prostate arteries in ultra-high-resolution mode. Four reconstruction approaches were evaluated: conventional reconstructions with (1) standard of care kernel and (2) sharper kernel (Bv64), along with (3) monoenergetic 50 keV, and (4) iodine map spectral results. Using commercial embolization guidance software, three vessels were manually traced for each patient to establish ground truth segmentation. Subsequently, automatic vessel traces were generated using identical start/end points as the ground truth. Root mean squared error (RMSE) between automatic traces and ground truth was used to quantify tracing accuracy.
resultsComparing individual traces, iodine maps demonstrated consistency with median RMSE of 0.7 mm (0.4 mm interquartile range (IQR)) versus 0.7 mm (12.5 mm IQR), 1.5 mm (14.7 mm IQR), and 0.8 mm (6.7 mm IQR) for Bv56, Bv64, and 50 keV reconstructions, respectively. Iodine maps produced fewer outliers, with 13.3% of traces and 40.0% of patients having one or more traces exceeding 5 mm RMSE, compared with 26.7%-36.7% of traces and 60.0%-80.0% of patients for the other reconstructions.
conclusionsMaterial-specific iodine reconstructions from PCD-CT yield more robust automatic vessel tracing for PAE planning, offering a workflow-compatible solution requiring minimal protocol modifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.